GABAPENTIN (GABAPENTIN) — FDA Approval ANDA203611 (ACTAVIS ELIZABETH)
GABAPENTIN (GABAPENTIN) — FDA Approval ANDA203611 (ACTAVIS ELIZABETH) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: GABAPENTIN; Active ingredients: GABAPENTIN; Application number: ANDA203611.
| Brand name | GABAPENTIN |
|---|---|
| Active ingredients | GABAPENTIN |
| Application number | ANDA203611 |
| Sponsor | ACTAVIS ELIZABETH |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | None (Tentative Approval) |
| Products in application | 2 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →